title: RF latex and anti-CCP antibodies: a combined strategy for diagnosing RA in primary care?
authors.forename: A
authors.initials: A
authors.lastname: Steuer
authors.forename: J
authors.initials: J
authors.lastname: Watkins
authors.forename: F
authors.initials: F
authors.lastname: Smith
authors.forename: L
authors.initials: L
authors.lastname: Day
authors.forename: F
authors.initials: F
authors.lastname: Demetriadi
authors.forename: H
authors.initials: H
authors.lastname: Chapel
mesh_terms: D001172:Arthritis, Rheumatoid / Q000175:diagnosis* / Q000276:immunology; D005260:Female; D006801:Humans; D007840:Latex; D008297:Male; D008403:Mass Screening / Q000379:methods; D010456:Peptides, Cyclic / Q000097:blood / Q000276:immunology*; D010865:Pilot Projects; D011320:Primary Health Care; D011446:Prospective Studies; D012217:Rheumatoid Factor / Q000097:blood / Q000276:immunology*; D012680:Sensitivity and Specificity; D012698:Serologic Tests / Q000379:methods; D006113:United Kingdom
chemical_list: D007840:Latex; D010456:Peptides, Cyclic; C487763:cyclic citrullinated peptide; D012217:Rheumatoid Factor